Abstract
This study presents preliminary psychometric findings of the QUEST_Resilience Mapping Scale (Adult Version), developed to evaluate belief systems underlying resilient behaviors in daily contexts. Based on the Resilient Approach (ARslnt) proposed by Barbosa, the scale defines resilience as a neurocognitive process involving the strategic regulation of beliefs and emotional responses through eight independent yet interrelated Belief Model Determinants. These models were statistically validated as distinct cognitive structures that, when coordinated, guide the attribution of meaning and intensity to thoughts, emotions, and behaviors in adversity.
Unlike personality inventories, the QUEST_Resilience Scale functions as a belief-mapping tool. It comprises 72 Likert-scale items across the eight Belief Model Determinants (BMDs): Self-Control, Conscious Stress Reactions, Context Analysis, Optimism toward Life, Self-Confidence, Enchantment and Maintenance of People, Empathy, and Meaning of Life. Responses are interpreted through three behavioral patterns—Passivity, Intolerance, and Balance—classified into four resilience conditions: Weak, Moderate, Good, and Strong. An additional level, Excellent, reflects balanced cognitive functioning across all BMDs. If more than three BMDs fall within the “Weak” condition, cognitive vulnerability is indicated, recommending psychological and/or medical follow-up.
The scale underwent semantic validation by 13 experts in Education and Health, with data collected from adults between 2008 and 2010 via SOBRARE's online platform. There were no exclusion criteria regarding gender, marital status, religion, or education. Beyond cognitive mapping, the instrument includes sociodemographic and life history data to create personalized resilience profiles.
The QUEST_Resilience Scale has wide applications in clinical psychology, resilience-based interventions, coaching, and educational settings. It has also supported empirical studies on coping, stress management, and emotional regulation. Its use requires prior authorization from SOBRARE, which oversees its ethical and legal distribution. Statistical analyses demonstrated internal reliability and factorial coherence, providing evidence of its viability for clinical and academic purposes.